Randomized, double-blind, placebo-controlled trial of acetaminophen for preventing mood and memory effects of prednisone bursts

Allergy and Asthma Proceedings

Volumn 31, Issue 4, 2010, Pages 331-336

  Brown, E Sherwood ^a   Denniston, Daren ^a   Gabrielson, Barry ^a   Khan, David A ^b   Khanani, Sadia ^a   Desai, Shuchi ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Acetaminophen; Cognition; Corticosteroid; Depression; Hippocampus; Mania; Memory; Prednisone; Prevention

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTACID AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPNOTIC AGENT; ISOMETHEPTENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LITHIUM; MINERAL; MUSCLE RELAXANT AGENT; NARCOTIC ANALGESIC AGENT; NICOTINE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PARACETAMOL; PLACEBO; PREDNISONE; STEROID; THEOPHYLLINE; VITAMIN;

ADD ON THERAPY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLERGIC RHINITIS; ANALYSIS OF COVARIANCE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DECLARATIVE MEMORY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; HAMILTON SCALE; HUMAN; INTERNAL STATE SCALE; MALE; MEMORY DISORDER; MOOD CHANGE; OUTPATIENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; STUDENT T TEST; YOUNG MANIA RATING SCALE;

ACETAMINOPHEN; ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EMOTIONS; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MEMORY, LONG-TERM; MIDDLE AGED; MOOD DISORDERS; NEUROPROTECTIVE AGENTS; PREDNISONE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 77956314664     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3338     Document Type: Article

References (45)

1. Skoner JD, Schaffner TJ, Schad CA, et al. Addressing steroid phobia: Improving the risk-benefit ratio with new agents. Allergy Asthma Proc 29:358-364, 2008.
2. Brown ES, JA Rush, and McEwen BS. Hippocampal remodeling and damage by corticosteroids: Implications for mood disorders. Neuropsychopharmacology 21:474-484, 1999.
3. Brown ES, Varghese FP, and McEwen BS. Association of depression with medical illness: Does cortisol play a role? Biol Psychiatry 55:1-9, 2004.
4. McEwen BS. Possible mechanisms for atrophy of the human hippocampus. Mol Psychiatry 2:255-262, 1997. (Pubitemid 27217691)
5. McEwen BS. The neurobiology of stress: From serendipity to clinical relevance. Brain Res 886:172-189, 2000.
6. Brown ES, Woolston JD, Frol A, et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 55:538-545, 2004. (Pubitemid 38338543)
7. Starkman MN, Gebarski SS, Berent S, et al. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 32:756-765, 1992.
8. Eichenbaum H, Otto T, and Cohen NJ. The hippocampus - What does it do? Behav Neural Biol 57:2-36, 1992.
9. Squire LR. Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans. Psychol Rev 99:195-231, 1992.
10. Bender BG, Lerner JA, and Kollasch E. Mood and memory changes in asthmatic children receiving corticosteroids. J Am Acad Child Adolesc Psychiatry 27:720-725, 1988. (Pubitemid 19003711)
11. Brown ES, Beard L, Frol AB, et al. Effect of two prednisone exposures on mood and declarative memory. Neurobiol Learn Mem 86:28-34, 2006. (Pubitemid 43776641)
12. Naber D, Sand P, and Heigl B. Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study. Psychoneuroendocrinology 21:25-31, 1996. (Pubitemid 26129276)
13. Newcomer JW, Graft S, Hershey T, et al. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci 14:2047-2053, 1994. (Pubitemid 24108114)
14. Newcomer JW, Salke G, Melson AK, et al. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 56:527-533, 1999.
15. Keenan PA, Jacobson MW, Soleymani RM, et al. The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology 47:1396-1402, 1996. (Pubitemid 26422526)
16. Brown ES. Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann N Y Acad Sci 1179:41-55, 2009.
17. Brown ES, Suppes T, Khan DA, et al. Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol 22:55-61, 2002. (Pubitemid 34101293)
18. Brown ES, and Chandler PA. Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry 3:17-21, 2001. (Pubitemid 33807485)
19. Bolanos SH, Khan DA, Hanczyc M, et al. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol 92:500-505, 2004. (Pubitemid 39236812)
20. Conrad CD, Galea LA, Kuroda Y, et al. Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci 110:1321-1334, 1996. (Pubitemid 27009196)
21. Magarinos AM, Deslandes A, and McEwen BS. Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol 371:113-122, 1999. (Pubitemid 29216993)
22. Watanabe Y, Gould E, Daniels DC, et al. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol 222:157-162, 1992.
23. Falk WE, Mahnke MW, and Poskanzer DC. Lithium prophylaxis of corticotropin-induced psychosis. JAMA 241:1011-1012, 1979.
24. Brown ES, Wolfshohl J, Shad WU, et al. Attenuation of the effects of corticosteroids on declarative memory with lamotrigine. Neuropsychopharmacology 33:2376-2383, 2008.
25. Brown ES, Vazquez M, and Nakamura A. Randomized, placebocontrolled, crossover trial of memantine for cognitive changes with corticosteroid therapy. Biol Psychiatry 64:727-729, 2008.
26. Brown ES, Stuard G, Liggin JD, et al. Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy. Biol Psychiatry 57:543-548, 2005. (Pubitemid 40311990)
27. Brown ES. Effects of glucocorticoids on mood, memory, and the hippocampus: Treatment and preventive therapy. Ann NY Acad Sci. 1179:41-55, 2009.
28. Courad JP, Besse D, Delchambre C, et al. Acetaminophen distribution in the rat central nervous system. Life Sci 69:1455-1464, 2001. (Pubitemid 32758712)
29. Casper D, Lekhraj R, Yaparpalvi US, et al. Acetaminophen selectively reduces glioma cell growth and increases radiosensitivity in culture. J Neurooncol 46:215-229, 2000.
30. Bisaglia M, Venezia V, Piccioli P, et al. Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid beta-peptides induced oxidative stress and reduces NF-kappaB activation. Neurochem Int 41:43-54, 2002. (Pubitemid 34251405)
31. Huang WT, Wang JJ, and Lin MT. Antipyretic effect of acetaminophen by inhibition of glutamate release after staphylococcal enterotoxin A fever in rabbits. Neurosci Lett 355:33-36, 2004.
32. Courad JP, Caussade F, Martin K, et al. Effects of acetaminophen on monoaminergic systems in the rat central nervous system. Naunyn Schmiedebergs Arch Pharmacol 364:534-537, 2001. (Pubitemid 33145093)
33. Chen C, and Bazan NG. Acetaminophen modifies hippocampal synaptic plasticity via a presynaptic 5-HT2 receptor. Neuroreport 14:743-747, 2003. (Pubitemid 36570934)
34. Bauer MS, Crits-Christoph P, Ball WA, et al. Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania. Arch Gen Psychiatry 48:807-812, 1991.
35. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62, 1960.
36. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 133:429-435, 1978.
37. Rosenberg SJ, Ryan JJ, and Prifitera A. Rey Auditory-Verbal Learning Test performance of patients with and without memory impairment. J Clin Psychol 40:785-787, 1984. (Pubitemid 14075299)
38. Busse WW, Boushey HA, and Camargo CA. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 120(suppl):S94 -138, 2007.
39. Juniper EF, O'Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 14:902-907, 1999. (Pubitemid 29519356)
40. Thase ME, Fava M, Halbreich U, et al. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 53:777-784, 1996. (Pubitemid 26303618)
41. Brown ES, Vigil L, Khan DA, et al. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: A proof of concept study. Biol Psychiatry 58:865-870, 2005. (Pubitemid 41790714)
42. Brown ES, Frol AB, Khan DA, et al. Impact of levetiracetam on mood and cognition during prednisone therapy. Eur Psychiatry 22:448-452, 2007. (Pubitemid 47600622)
43. Brown ES, Khan DA, and Mahadi S. Psychiatric diagnoses in inner city outpatients with moderate to severe asthma. Int J Psychiatry Med 30:319-327, 2000. (Pubitemid 32238565)
44. Arana GW, Santos AB, Laraia MT, et al. Dexamethasone for the treatment of depression: A randomized, placebo-controlled, double-blind trial. Am J Psychiatry 152:265-267, 1995.
45. The Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 13:694-698, 1972.